Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4773)
All Articles published online
|
Jul 28, 2012 (publication date) through May 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhu YF, Yu BH, Li DL, Ke HL, Guo XZ, Xiao XY. PI3K expression and PIK3CA mutations are related to colorectal cancer metastases. World J Gastroenterol 2012; 18(28): 3745-3751 [PMID: 22851869 DOI: 10.3748/wjg.v18.i28.3745] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i28/3745.htm |
| Number | Citing Articles |
| 1 |
Ae-Jin Jeong, Chung-Nam Chung, Hye-Jin Kim, Kil Soo Bae, Song Choi, Woo Jin Jun, Sang In Shim, Tae-Hong Kang, Sun-Hee Leem, Jin Woong Chung. GeckoProteins Exert Anti-Tumor Effect against Cervical Cancer Cells Via PI3-Kinase/Akt Pathway. The Korean Journal of Physiology & Pharmacology 2012; 16(5): 361 doi: 10.4196/kjpp.2012.16.5.361
|
| 2 |
Amanda I. Phipps, Dennis J. Ahnen, Iona Cheng, Polly A. Newcomb, Aung Ko Win, Terrilea Burnett.
PIK3CA Somatic Mutation Status in Relation to Patient and Tumor Factors in Racial/Ethnic Minorities with Colorectal Cancer. Cancer Epidemiology, Biomarkers & Prevention 2015; 24(7): 1046 doi: 10.1158/1055-9965.EPI-15-0204
|
| 3 |
Hamed Manoochehri, Mohsen Sheykhhasan, Pouria Samadi, Mona Pourjafar, Massoud Saidijam. System biological and experimental validation of miRNAs target genes involved in colorectal cancer radiation response. Gene Reports 2019; 17: 100540 doi: 10.1016/j.genrep.2019.100540
|
| 4 |
Lin Wang, Ling Shan, Shaokai Zhang, Jianming Ying, Liyan Xue, Yanling Yuan, Yongqiang Xie, Ning Lu, Hiromu Suzuki. PIK3CA Gene Mutations and Overexpression: Implications for Prognostic Biomarker and Therapeutic Target in Chinese Esophageal Squamous Cell Carcinoma. PLoS ONE 2014; 9(7): e103021 doi: 10.1371/journal.pone.0103021
|
| 5 |
Atiye Seda Yar Saglam, Ebru Alp, Zubeyir Elmazoglu, Emine Sevda Menevse. Effect of API-1 and FR180204 on cell proliferation and apoptosis in human DLD-1 and LoVo colorectal cancer cells. Oncology Letters 2016; 12(4): 2463 doi: 10.3892/ol.2016.4995
|
| 6 |
Chenlan Shen, Bo Shen, Fei Mo, Xiaoyan Zhou, Xiaolei Duan, Xiaotong Wei, Jia Li, Yu Duan, Wei Cheng, Shijia Ding. High-sensitive colorimetric biosensing of PIK3CA gene mutation based on mismatched ligation-triggered cascade strand displacement amplification. Sensors and Actuators B: Chemical 2018; 273: 377 doi: 10.1016/j.snb.2018.06.041
|
| 7 |
Min Dong, Hai-yan Wang, Xiao-xiao Zhao, Jian-ning Chen, Yi-wang Zhang, Yan Huang, Ling Xue, Hai-gang Li, Hong Du, Xiang-yuan Wu, Chun-kui Shao. Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus–associated gastric carcinoma. Human Pathology 2016; 53: 25 doi: 10.1016/j.humpath.2016.02.007
|
| 8 |
David C. Qian, Xiangjun Xiao, Jinyoung Byun, Arief A. Suriawinata, Stephanie C. Her, Christopher I. Amos, Richard J. Barth. PI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer. Clinical Cancer Research 2017; 23(2): 399 doi: 10.1158/1078-0432.CCR-16-0623
|
| 9 |
Deniz Tural, Sebnem Batur, Sibel Erdamar, Emre Akar, Nuray Kepil, Nil Molinas Mandel, Süheyla Serdengeçti. Analysis of PTEN, BRAF and PI3K status for determination of benefit from cetuximab therapy in metastatic colorectal cancer patients refractory to chemotherapy with wild-type KRAS. Tumor Biology 2014; 35(2): 1041 doi: 10.1007/s13277-013-1138-8
|
| 10 |
Lei Wang, Haichuan Hu, Yunjian Pan, Rui Wang, Yuan Li, Lei Shen, Yongfu Yu, Hang Li, Deng Cai, Yihua Sun, Haiquan Chen, Giuseppe Viglietto. PIK3CA Mutations Frequently Coexist with EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup. PLoS ONE 2014; 9(2): e88291 doi: 10.1371/journal.pone.0088291
|
| 11 |
Christoph Treese, Kimberly Hartl, Michelle Pötzsch, Matthias Dahlmann, Moritz von Winterfeld, Erika Berg, Michael Hummel, Lena Timm, Beate Rau, Wolfgang Walther, Severin Daum, Dennis Kobelt, Ulrike Stein. S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus. Cells 2022; 11(6): 1056 doi: 10.3390/cells11061056
|
| 12 |
Mirjana Prvanović, Milica Nedeljković, Nasta Tanić, Tijana Tomić, Tanja Terzić, Zorka Milovanović, Zlatko Maksimović, Nikola Tanić. Role of PTEN, PI3K, and mTOR in Triple-Negative Breast Cancer. Life 2021; 11(11): 1247 doi: 10.3390/life11111247
|
| 13 |
Xuemei Xie, Jangsoon Lee, Jon A. Fuson, Huey Liu, Toshiaki Iwase, Kyuson Yun, Cori Margain, Debu Tripathy, Naoto T. Ueno. Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines. Biomedicines 2023; 11(3): 735 doi: 10.3390/biomedicines11030735
|
| 14 |
Jing Chen, Fang Guo, Xin Shi, Lihua Zhang, Aifeng Zhang, Hui Jin, Youji He. BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-802
|
| 15 |
Shuhua Wu, Feifei Wen, Yangyang Li, Xiangqian Gao, Shuang He, Mengyao Liu, Xiangzhi Zhang, Dong Tian. PIK3CA and PIK3CB silencing by RNAi reverse MDR and inhibit tumorigenic properties in human colorectal carcinoma. Tumor Biology 2016; 37(7): 8799 doi: 10.1007/s13277-015-4691-5
|
| 16 |
Kailv Sun, Sheng Wang, Jun He, Yufeng Xie, Yang He, Zhenxin Wang, Lei Qin. NCOA5 promotes proliferation, migration and invasion of colorectal cancer cells via activation of PI3K/AKT pathway. Oncotarget 2017; 8(64): 107932 doi: 10.18632/oncotarget.22429
|
| 17 |
Jonathan M. Kocarnik, Stacey Shiovitz, Amanda I. Phipps. Molecular phenotypes of colorectal cancer and potential clinical applications. Gastroenterology Report 2015; : gov046 doi: 10.1093/gastro/gov046
|
| 18 |
Ga Bin Park, Daejin Kim. Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial–mesenchymal transition through the regulation of ADAM10 and ADAM17. Molecular and Cellular Biochemistry 2018; 439(1-2): 199 doi: 10.1007/s11010-017-3148-0
|
| 19 |
Yun Ju Lee, Woo Ryung Kim, Eun Gyung Park, Du Hyeong Lee, Jung-min Kim, Hae Jin Shin, Hyeon-su Jeong, Hyun-Young Roh, Heui-Soo Kim. Exploring the Key Signaling Pathways and ncRNAs in Colorectal Cancer. International Journal of Molecular Sciences 2024; 25(8): 4548 doi: 10.3390/ijms25084548
|
| 20 |
Humzah Postwala, Yesha Shah, Priyajeet S. Parekh, Mehul R. Chorawala. Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways. Medical Oncology 2023; 40(11) doi: 10.1007/s12032-023-02201-8
|
| 21 |
Hong Jun Kim, Suk-young Lee, Sang Cheul Oh. The Inositide Signaling Pathway As a Target for Treating Gastric Cancer and Colorectal Cancer. Frontiers in Physiology 2016; 7 doi: 10.3389/fphys.2016.00168
|
| 22 |
Mohammad Azhar Aziz, Zeyad Yousef, Ayman M. Saleh, Sameer Mohammad, Bandar Al Knawy. Towards personalized medicine of colorectal cancer. Critical Reviews in Oncology/Hematology 2017; 118: 70 doi: 10.1016/j.critrevonc.2017.08.007
|
| 23 |
Michelle Palmieri, Bruno Catimel, Dmitri Mouradov, Anuratha Sakthianandeswaren, Eugene Kapp, Ching-Seng Ang, Nicholas A. Williamson, Cameron J. Nowell, Michael Christie, Jayesh Desai, Peter Gibbs, Antony W. Burgess, Oliver M. Sieber. PI3Kα Translocation Mediates Nuclear PtdIns(3,4,5)P3 Effector Signaling in Colorectal Cancer. Molecular & Cellular Proteomics 2023; 22(4): 100529 doi: 10.1016/j.mcpro.2023.100529
|
| 24 |
Dionysios Papadatos-Pastos, Roy Rabbie, Paul Ross, Debashis Sarker. The role of the PI3K pathway in colorectal cancer. Critical Reviews in Oncology/Hematology 2015; 94(1): 18 doi: 10.1016/j.critrevonc.2014.12.006
|
| 25 |
The sensitivity and efficacy method of PIK3CA exon 9 E545A as a high diagnostic accuracy in breast cancer. Journal of Genetic Engineering and Biotechnology 2018; 16(1): 71 doi: 10.1016/j.jgeb.2017.10.002
|
| 26 |
Tomoya Takeda, Yuuta Yamamoto, Masanobu Tsubaki, Takuya Matsuda, Akihiro Kimura, Natsumi Shimo, Shozo Nishida. PI3K/Akt/YAP signaling promotes migration and invasion of DLD‑1 colorectal cancer cells. Oncology Letters 2022; 23(4) doi: 10.3892/ol.2022.13226
|
| 27 |
Premila D. Leiphrakpam, Senthil J. Rajappa, Mridula Krishnan, Rishi Batra, Shilpa S. Murthy, Chandrakanth Are. Colorectal cancer: Review of signaling pathways and associated therapeutic strategies. Journal of Surgical Oncology 2023; 127(8): 1277 doi: 10.1002/jso.27295
|
| 28 |
Mingjie Li, Dandan Guo, Xijun Chen, Xinxin Lu, Xiaoli Huang, Yan’an Wu. Transcriptome profiling and co-expression network analysis of lncRNAs and mRNAs in colorectal cancer by RNA sequencing. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09878-6
|
| 29 |
Amitabha Ray, Margot P. Cleary. The potential role of leptin in tumor invasion and metastasis. Cytokine & Growth Factor Reviews 2017; 38: 80 doi: 10.1016/j.cytogfr.2017.11.002
|
| 30 |
Li Liu, Yung Chang, Tao Yang, David P Noren, Byron Long, Steven Kornblau, Amina Qutub, Jieping Ye. Evolution‐informed modeling improves outcome prediction for cancers. Evolutionary Applications 2017; 10(1): 68 doi: 10.1111/eva.12417
|
| 31 |
Dorota Anusewicz, Magdalena Orzechowska, Andrzej K. Bednarek. Lung squamous cell carcinoma and lung adenocarcinoma differential gene expression regulation through pathways of Notch, Hedgehog, Wnt, and ErbB signalling. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77284-8
|
| 32 |
Premila Leiphrakpam, Chandrakanth Are. PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment. International Journal of Molecular Sciences 2024; 25(6): 3178 doi: 10.3390/ijms25063178
|
| 33 |
Siew-Wai Pang, Noel Jacques Awi, Subasri Armon, Wendy Wan-Dee Lim, John Seng-Hooi Low, Kaik-Boo Peh, Suat-Cheng Peh, Sin-Yeang Teow. Current Update of Laboratory Molecular Diagnostics Advancement in Management of Colorectal Cancer (CRC). Diagnostics 2019; 10(1): 9 doi: 10.3390/diagnostics10010009
|
| 34 |
Yu-Chan Chang, Ming-Hsien Chan, Chien-Hsiu Li, Chih-Yeu Fang, Michael Hsiao, Chi-Long Chen. Exosomal Components and Modulators in Colorectal Cancer: Novel Diagnosis and Prognosis Biomarkers. Biomedicines 2021; 9(8): 931 doi: 10.3390/biomedicines9080931
|
| 35 |
Shubham Pant, Joleen Hubbard, Erika Martinelli, Tanios Bekaii-Saab. Clinical update on K-Ras targeted therapy in gastrointestinal cancers. Critical Reviews in Oncology/Hematology 2018; 130: 78 doi: 10.1016/j.critrevonc.2018.07.011
|
| 36 |
Debojyoti Halder, Subham Das, R. S. Jeyaprakash. Identification of natural product as selective PI3Kα inhibitor against NSCLC: multi-ligand pharmacophore modeling, molecular docking, ADME, DFT, and MD simulations. Molecular Diversity 2023; doi: 10.1007/s11030-023-10727-2
|
| 37 |
Jing-wei Lin, Xu Li, Ming-lian Qiu, Rong-gang Luo, Jian-bo Lin, Bo Liu. PI3K Overexpression andPIK3CAMutations Are Associated with Age, Tumor Staging, and Other Clinical Characteristics in Chinese Patients with Esophageal Squamous Cell Carcinoma. Genetic Testing and Molecular Biomarkers 2017; 21(4): 236 doi: 10.1089/gtmb.2016.0316
|
| 38 |
Mahatma Ortega, Jessica Sparks, Victor E. Nava, Shane D. B. Smith. Neurothekeoma With PI3K w552*, ALK P1469S, SMO G461S, and ERBB3 L77M Genetic Alterations. The American Journal of Dermatopathology 2022; 44(12): 958 doi: 10.1097/DAD.0000000000002292
|
| 39 |
Cristiana Caliceti, Angela Punzo, Alessia Silla, Patrizia Simoni, Giulia Roda, Silvana Hrelia. New Insights into Bile Acids Related Signaling Pathways in the Onset of Colorectal Cancer. Nutrients 2022; 14(14): 2964 doi: 10.3390/nu14142964
|
| 40 |
Ji-Hyun Yeom, Eunkyoung Shin, Hanyong Jin, Haifeng Liu, Yongyang Luo, Youngwoo Nam, Minkyung Ryu, Wooseok Song, Heeyoun Chi, Jeongkyu Kim, Kangseok Lee, Jeehyeon Bae. Aptamer-conjugated gold nanoparticles platform as the intracellular delivery of antibodies for cancer therapy. Journal of Industrial and Engineering Chemistry 2023; 126: 480 doi: 10.1016/j.jiec.2023.06.036
|
| 41 |
Stine Aske Danielsen, Peter Wold Eide, Arild Nesbakken, Tormod Guren, Edward Leithe, Ragnhild A. Lothe. Portrait of the PI3K/AKT pathway in colorectal cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2015; 1855(1): 104 doi: 10.1016/j.bbcan.2014.09.008
|
| 42 |
Silvina Grasso, Isabel Martínez-Lacaci, Víctor Manuel Barberá, Adela Castillejo, José Luis Soto, Javier Gallego-Plazas, Natividad López-Riquelme, Pilar García-Morales, Trinidad Mata-Balaguer, José Antonio Ferragut, Miguel Saceda. HGUE-C-1 is an atypical and novel colon carcinoma cell line. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1183-3
|
| 43 |
Anna Starzyńska, Paulina Adamska, Aleksandra Sejda, Monika Sakowicz-Burkiewicz, Łukasz Jan Adamski, Giulia Marvaso, Piotr Wychowański, Barbara Alicja Jereczek-Fossa. Any Role of PIK3CA and PTEN Biomarkers in the Prognosis in Oral Squamous Cell Carcinoma?. Life 2020; 10(12): 325 doi: 10.3390/life10120325
|
| 44 |
Maria Radanova, Galya Mihaylova, Zhasmina Mihaylova, Desislava Ivanova, Oskan Tasinov, Neshe Nazifova-Tasinova, Pavel Pavlov, Milko Mirchev, Nikolay Conev, Ivan Donev. Circulating miR-618 Has Prognostic Significance in Patients with Metastatic Colon Cancer. Current Oncology 2021; 28(2): 1204 doi: 10.3390/curroncol28020116
|
| 45 |
Igor P. Oscorbin, Oguljan P. Beginyazova, Inna V. Khlistun, Darya V. Shamovskaya, Natalia A. Oskina, Maxim L. Filipenko. Development of a multiplex allele-specific qPCR approach for testing PIK3CA mutations in patients with colorectal cancer. Heliyon 2022; 8(11): e11804 doi: 10.1016/j.heliyon.2022.e11804
|
| 46 |
Asif Khurshid Qazi, Aashiq Hussain, Saima Khan, Mushtaq A. Aga, Akanksha Behl, Shakir Ali, Shashank Kumar Singh, Subhash Chandra Taneja, Bhahwal Ali Shah, Ajit Kumar Saxena, Dilip Manikrao Mondhe, Abid Hamid. Quinazoline based small molecule exerts potent tumour suppressive properties by inhibiting PI3K/Akt/FoxO3a signalling in experimental colon cancer. Cancer Letters 2015; 359(1): 47 doi: 10.1016/j.canlet.2014.12.034
|
| 47 |
Sabina Palma, Ariel O. Zwenger, María V. Croce, Martín C. Abba, Ezequiel Lacunza. From Molecular Biology to Clinical Trials: Toward Personalized Colorectal Cancer Therapy. Clinical Colorectal Cancer 2016; 15(2): 104 doi: 10.1016/j.clcc.2015.11.001
|